These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32928961)

  • 1. The solution structure of the complement deregulator FHR5 reveals a compact dimer and provides new insights into CFHR5 nephropathy.
    Kadkhodayi-Kholghi N; Bhatt JS; Gor J; McDermott LC; Gale DP; Perkins SJ
    J Biol Chem; 2020 Nov; 295(48):16342-16358. PubMed ID: 32928961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.
    Osborne AJ; Nan R; Miller A; Bhatt JS; Gor J; Perkins SJ
    J Biol Chem; 2018 Nov; 293(44):17166-17187. PubMed ID: 30217822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
    Furtado PB; Huang CY; Ihyembe D; Hammond RA; Marsh HC; Perkins SJ
    J Mol Biol; 2008 Jan; 375(1):102-18. PubMed ID: 18028942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.
    Aslam M; Perkins SJ
    J Mol Biol; 2001 Jun; 309(5):1117-38. PubMed ID: 11399083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
    Li K; Gor J; Holers VM; Storek MJ; Perkins SJ
    J Mol Biol; 2012 May; 418(3-4):248-63. PubMed ID: 22387467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHR5 Binds to Laminins, Uses Separate C3b and Surface-Binding Sites, and Activates Complement on Malondialdehyde-Acetaldehyde Surfaces.
    Rudnick RB; Chen Q; Stea ED; Hartmann A; Papac-Milicevic N; Person F; Wiesener M; Binder CJ; Wiech T; Skerka C; Zipfel PF
    J Immunol; 2018 Apr; 200(7):2280-2290. PubMed ID: 29483359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering.
    Perkins SJ; Nealis AS; Sim RB
    Biochemistry; 1991 Mar; 30(11):2847-57. PubMed ID: 1826087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
    Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
    J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.
    Gilbert HE; Eaton JT; Hannan JP; Holers VM; Perkins SJ
    J Mol Biol; 2005 Feb; 346(3):859-73. PubMed ID: 15713468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
    Aslam M; Guthridge JM; Hack BK; Quigg RJ; Holers VM; Perkins SJ
    J Mol Biol; 2003 Jun; 329(3):525-50. PubMed ID: 12767833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dimerization Site at SCR-17/18 in Factor H Clarifies a New Mechanism for Complement Regulatory Control.
    Dunne OM; Gao X; Nan R; Gor J; Adamson PJ; Gordon DL; Moulin M; Haertlein M; Forsyth VT; Perkins SJ
    Front Immunol; 2020; 11():601895. PubMed ID: 33552059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.
    Papp A; Papp K; Uzonyi B; Cserhalmi M; Csincsi ÁI; Szabó Z; Bánlaki Z; Ermert D; Prohászka Z; Erdei A; Ferreira VP; Blom AM; Józsi M
    Front Immunol; 2022; 13():845953. PubMed ID: 35392081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH; Gitterman DP; Lavin DP; Lomax-Browne HJ; Hiemeyer EC; Moran LB; Boroviak K; Cook HT; Gilmore AC; Mandwie M; Ahmad A; Alexander IE; Logan GJ; Marchbank KJ; Bradley A; Pickering MC
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties.
    Okemefuna AI; Gilbert HE; Griggs KM; Ormsby RJ; Gordon DL; Perkins SJ
    J Mol Biol; 2008 Jan; 375(1):80-101. PubMed ID: 18005991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3.
    Li K; Gor J; Perkins SJ
    Biochem J; 2010 Oct; 431(1):63-72. PubMed ID: 20666732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structures of complement components by X-ray and neutron scattering and analytical ultracentrifugation.
    Perkins SJ; Gilbert HE; Aslam M; Hannan J; Holers VM; Goodship TH
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):996-1001. PubMed ID: 12440960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.
    Sun Z; Reid KB; Perkins SJ
    J Mol Biol; 2004 Nov; 343(5):1327-43. PubMed ID: 15491616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain structure of human complement C4b extends with increasing NaCl concentration: implications for its regulatory mechanism.
    Fung KW; Wright DW; Gor J; Swann MJ; Perkins SJ
    Biochem J; 2016 Dec; 473(23):4473-4491. PubMed ID: 27738201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
    Gilbert HE; Aslam M; Guthridge JM; Holers VM; Perkins SJ
    J Mol Biol; 2006 Feb; 356(2):397-412. PubMed ID: 16375923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin.
    Fernando AN; Furtado PB; Clark SJ; Gilbert HE; Day AJ; Sim RB; Perkins SJ
    J Mol Biol; 2007 Apr; 368(2):564-81. PubMed ID: 17362990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.